GlaxoSmithKline PLC (GSK)

NYSE: Health Care

Get a 5-page Ratings Report on (GSK) now

$51.48

-0.99 | -1.89%

Today's Range: 51.46 - 52.49

GSK Avg. Daily Volume: 2,946,800

06/19/13 - 4:01 PM ET

Latest Dividend: 0.55
Latest Dividend Yield: 4.45%
Dividend Ex-Date: 05/08/13
Price Earnings Ratio: 15.89

Price Earnings Comparisons:

GSK	Sector Avg.	S&P 500
15.89	19.70	17.70

Price Performance History
(% change):

3 Mo	1 Yr	3 Yr
16.29%	15.47%	47.84%

GROWTH	12 Mo	3 Yr	CAGR
Revenue	0.50	-0.07	-0.02
Net Income	-9.50	-0.16	-0.06
EPS	-7.70	-0.15	-0.05

Earnings for GSK:

EBITDA	11.76B
REVENUE	42.71B

Average Earnings Estimates

	Qtr (06/13)	Qtr (09/13)	FY (12/13)	FY (12/14)

Average Estimate	$0.90	$0.92	$3.61	$3.96
Number of Analysts	2	2	6	5
High Estimate	$0.91	$0.96	$3.67	$4.08
Low Estimate	$0.88	$0.88	$3.56	$3.78
Prior Year	$0.82	$0.85	$3.58	$3.61
Growth Rate (Year over Year)	9.15%	8.24%	0.88%	9.53%

(GSK) News

5 Stocks Raising The Drugs Industry Higher
TheStreet.com | 06/17/13 - 01:03 PM EDT
Amicus Delays U.S. Approval Filing for Fabry Disease Drug
TheStreet.com | 06/17/13 - 08:43 AM EDT
Weekly Roundup
Action Alerts PLUS | 06/14/13 - 06:41 PM EDT
5 Buy-Rated Dividend Stocks: MO, PVR, GSK, EEP, EC
TheStreet.com | 06/13/13 - 11:30 AM EDT
Cashing Out
Action Alerts PLUS | 06/13/13 - 08:34 AM EDT
GlaxoSmithKline PLC (GSK): Today's Featured Drugs Winner
TheStreet.com | 06/12/13 - 05:00 PM EDT
Ask AAP
Action Alerts PLUS | 06/12/13 - 03:40 PM EDT
GlaxoSmithKline PLC Stock Buy Recommendation Reiterated (GSK)
TheStreet.com | 06/12/13 - 10:00 AM EDT
Playing Big Pharma's Strong Dividend Yields
TheStreet.com | 06/11/13 - 01:13 PM EDT
Weekly Roundup
Action Alerts PLUS | 06/07/13 - 06:43 PM EDT
FDA's Flawed Call On Aveo's Tivozanib
TheStreet.com | 06/07/13 - 05:06 PM EDT
As If Amarin Needs Another Worry, Here Comes A Vascepa FDA Panel
TheStreet.com | 06/06/13 - 11:10 AM EDT
Buying Weakness in Two Holdings
Action Alerts PLUS | 06/04/13 - 10:21 AM EDT
'Mad Money' Lightning Round: I'm Buying Under Armour
TheStreet.com | 06/04/13 - 06:00 AM EDT
Cramer's 'Mad Money' Recap: Out With the New
TheStreet.com | 06/03/13 - 08:29 PM EDT
ASCO '13: Array Drug First to be Effective Against Melanoma of the Eye
TheStreet.com | 06/01/13 - 07:35 AM EDT
Adjusting Our Healthcare Exposure
Action Alerts PLUS | 05/30/13 - 10:13 AM EDT
Adding to Three Positions and Trimming One
Action Alerts PLUS | 05/29/13 - 10:15 AM EDT
GlaxoSmithKline PLC Stock Buy Recommendation Reiterated (GSK)
TheStreet.com | 05/29/13 - 10:00 AM EDT
GlaxoSmithKline Stock Hits New 52-Week High (GSK)
TheStreet.com | 05/28/13 - 12:29 PM EDT
An Armful of Trades
Action Alerts PLUS | 05/28/13 - 12:28 PM EDT
Big Pharma Wants Fish Oil After All, But At Half Amarin's Selling Price
TheStreet.com | 05/28/13 - 11:41 AM EDT
5 Buy-Rated Dividend Stocks: AEP, GSK, CVI, NGLS, RHP
TheStreet.com | 05/28/13 - 11:30 AM EDT
Prosensa IPO Filing Looks Good For Sarepta Therapeutics
TheStreet.com | 05/28/13 - 09:40 AM EDT
No Reason to Sell Here
Action Alerts PLUS | 05/23/13 - 08:58 AM EDT
Cramer's 'Mad Money' Recap: Ignore the Fed
TheStreet.com | 05/22/13 - 07:45 PM EDT
Benefiting From the Rotation To Cyclicals
Street Watch | 05/22/13 - 11:42 AM EDT
New Home Demand Drives Toll
Street Watch | 05/22/13 - 11:06 AM EDT
Adding to a Cyclical and a Defensive
Action Alerts PLUS | 05/22/13 - 10:35 AM EDT
Toll Reports Better-than-Expected Earnings: Ahead of the Ticker
TheStreet.com | 05/22/13 - 09:55 AM EDT

More (GSK) News

Select the service that is right for you!

COMPARE ALL SERVICES

Action Alerts PLUS

TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:

$2.5+ million portfolio
Large-cap and dividend focus
Intraday trade alerts from Cramer
Weekly roundups

TheStreet Quant Ratings

TRY IT FREE

New! $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:

Buy, hold, or sell recommendations for over 4,300 stocks
Unlimited research reports on your favorite stocks
A custom stock screener
Upgrade/downgrade alerts

Stocks Under $10

TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:

Model portfolio
Stocks trading below $10
Intraday trade alerts
Weekly roundups

Dividend Stock Advisor

TRY IT FREE

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:

Diversified model portfolio of dividend stocks
Alerts when market news affect the portfolio
Bi-weekly updates with exact steps to take - BUY, HOLD, SELL

Real Money Pro

TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:

Real Money + Doug Kass + 15 more Wall Street Pros
Intraday commentary & news
Ultra-actionable trading ideas

Options Profits

TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.